Clinical trial

Esomeprazole (NEXIUM) vs. Surgery

NCT00251927 · AstraZeneca, Industry · Completed

Key facts

NCT number NCT00251927
Title Esomeprazole (NEXIUM) vs. Surgery
Official title An Open, Randomized, Multicenter, Phase IIIB Study During 5 Years to Assess Long-term Efficacy and Tolerability of Esomeprazole Compared to Laparoscopic Anti-reflux Surgery in Adult Subjects With Gastroesophageal Reflux Disease - LOTUS.
Acronym LOTUS
Lead sponsor AstraZeneca, Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Gastroesophageal Reflux
Intervention type Drug, Procedure
Interventions esomeprazole, Laparoscopic fundoplication (surgery)
Enrollment 626
Start date Oct 1, 2001
Primary completion Apr 1, 2009
Completion Apr 1, 2009
First posted Nov 11, 2005
Last update posted Aug 8, 2012
Countries Austria, Belgium, Denmark, Finland, France, Germany, Iceland, Italy, Netherlands, Norway, Sweden, United Kingdom

At a glance

  • 10–99 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies